Delivery Order SPE2DB22D3019-SPE2DB25FK3RH

Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,882.12 firm-fixed-price delivery order covers the supply of 4,566,816,335 units of Losartan Potassium 100 mg tablets. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,566.06 firm-fixed-price delivery order is for the supply of 4,561,834,817 units of Losartan Potassium 50 mg tablets. The contract has an ultimate completion date of August 17, 2023 and was awarded on August 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,263.54, is a Delivery Order for the supply of 50 mg Losartan Potassium tablets. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.12 firm fixed-price delivery order is for the supply of 1,000 units of Losartan Potassium 100 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,677,679 units of Losartan Potassium 50 mg tablets. The $1,996.04 firm fixed price delivery order has an ultimate completion date of April 24, 2023 and was awarded on April 21, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,450.90, is a delivery order for the supply of Losartan Potassium 50 mg Tablets in 1,000-count packages. The contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This contract award, valued at $1,366.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Losartan Potassium 50 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is a firm-fixed-price delivery order with a completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHVD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,318.69, is for the delivery of 4,567,235,577 units of Losartan Potassium 50 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,415.25 for the delivery of 4,566,949,578 units of Losartan Potassium 50 mg tablets. The award has an ultimate completion date of January 16, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,048.50, is for the delivery of Losartan Potassium 50 mg tablets to support military healthcare programs. The contract has an ultimate completion date of February 14, 2024, and is a firm fixed-price, non-set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK3RH
    Delivery Order

This federal contract award, valued at $2,575.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Losartan Potassium 50 mg tablets in quantities of 1,000s. The contract has an ultimate completion date of May 22, 2025 and is not designated as a set-aside contract.

Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/20/25, 10:02 AM